Publication | Open Access

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients

Lymphoid NeoplasiaKinase Inhibitors R406MedicineMalignant Blood DisorderImmunologyCell DeathImmune Checkpoint InhibitorAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCell BiologyMacrophage-mediated Anti-tumor Activity